Fig. 4 TGF-βRI kinase inhibitor downregulates TGF-β1 and TGF-βRI mRNA expression levels post-demyelination. (A) Schematic representation of the treatment protocols using Tg(mbpa:qf2;quas:epntr-p2a-mcherry) zebrafish larvae. (B-E) RT-qPCR results for tgf-β1a, tgf-β1b, tgf-βr1a, and tgf-βr1b mRNA expression. The experiment was repeated thrice. The data are presented as the mean ± SD; n ≥ 20 independent experiments. P-values were calculated using one-way ANOVA followed by Tukey’s test. Significance is indicated by *P < 0.05, **P < 0.01, and ***P < 0.001 vs. DMSO; #P < 0.05, ##P < 0.01, and ###P < 0.001 vs. MTZ 18 h + E3 or MTZ 18 h + AZ.
Image
Figure Caption
Figure Data
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Biomed. Pharmacother.